CANDACE CASSADY: Open Payments
NPI 1093922718 · ANDALUSIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,376 in 94 payments from 30 companies in 2025. Trend: 2023 $2,157 · 2024 $2,177 · 2025 $2,376
Food & beverage: $2,280Education: $96
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 14 | $565 |
| Merck Sharp & Dohme LLC | 11 | $232 |
| Genentech USA, Inc. | 9 | $165 |
| Stemline Therapeutics Inc. | 2 | $146 |
| Novartis Pharmaceuticals Corporation | 8 | $135 |
| Amgen Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
| Daiichi Sankyo Inc. | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Eisai Inc. | 4 | $74 |
Products named: KEYTRUDA, MONJUVI, Orserdu, Jakafi, IMDELLTRA (AMG757), Zynyz, IMFINZI, Lenvima.
Industry payments across AL — which companies pay providers there.
